A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non‐alc33oholic fatty liver disease
2020
Molecular Systems Biology
The prevalence of non-alcoholic fatty liver disease (NAFLD) continues to increase dramatically, and there is no approved medication for its treatment. Recently, we predicted the underlying molecular mechanisms involved in the progression of NAFLD using network analysis and identified metabolic cofactors that might be beneficial as supplements to decrease human liver fat. Here, we first assessed the tolerability of the combined metabolic cofactors including l-serine, N-acetyl-l-cysteine (NAC),
doi:10.15252/msb.209495
pmid:32337855
fatcat:n4ulsvsi2jbl7ouyuys62yjek4